|
|
Volumn 64, Issue 4, 2009, Pages 763-768
|
|
A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen
a
|
|
Author keywords
Breast cancer; Docetaxel; Metastatic; Zosuquidar
|
|
Indexed keywords
DOCETAXEL;
PLACEBO;
ZOSUQUIDAR;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANAPHYLAXIS;
ANEMIA;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIZZINESS;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG STORAGE;
DRUG WITHDRAWAL;
EDEMA;
FATIGUE;
FEBRILE NEUTROPENIA;
FEMALE;
GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
HYPOKALEMIA;
HYPONATREMIA;
LEUKOPENIA;
LYMPHOCYTOPENIA;
MAJOR CLINICAL STUDY;
METASTASIS;
MONOTHERAPY;
MULTICENTER STUDY;
MULTIPLE CYCLE TREATMENT;
NEUTROPENIA;
OVERALL SURVIVAL;
PARESTHESIA;
PERIPHERAL EDEMA;
PERIPHERAL NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT CANCER;
SENSORY NEUROPATHY;
SIDE EFFECT;
SKIN EXFOLIATION;
THROMBOCYTOPENIA;
TREATMENT FAILURE;
TREATMENT RESPONSE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DIBENZOCYCLOHEPTENES;
DISEASE-FREE SURVIVAL;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM METASTASIS;
PLACEBOS;
QUINOLINES;
RECURRENCE;
TAXOIDS;
|
|
EID: 68149149796
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s00280-009-0925-9 Document Type: Article |
|
Times cited : (71)
|
|
References (13)
|
